Shares of diagnostic medicine company Dasa (DASA3) closed 13.69% higher, at R$3.82, with the advance intensifying as of 4pm (Brasilia time).
The movement was prompted by news from Valor Econômico that Amil had proposed merging the hospitals with Dasa. The report, citing sources, said the conversation between the two companies was “informal in nature.”
Find out how Dasa shares performed during Thursday's trading session below:
Continues after ad
According to the report, each company owns about 12 hospitals of well-known brands such as Nove de Julho, Samaritano, Pró-Cardático, Santa Paula, Leforte and others, with units distributed in different regions of the country.
The idea, according to sources, came from Amiel and now the proposal is on the table of Dasa, which is looking for ways to improve its operational efficiency and reduce debt. Last week, the Bueno family, which controls Dasa, contributed R$1.5 billion to the company's cash flow. This deal is linked to a capital increase and the sale of an asset worth at least R$2.5 billion by the end of the year. The company is in negotiations to sell a minority stake in its diagnostic medicine business with a foreign group operating in the same sector.
Charlotte Whitmore is a contributor at Mediarunsearch.co.uk, covering a broad range of topics including news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on delivering clear, balanced reporting and practical information that helps readers stay informed about current events and emerging developments. Her work highlights stories that matter to everyday audiences, with an emphasis on accuracy, relevance, and accessible journalism that keeps readers connected to the issues shaping the UK and beyond.